Cargando…

Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy

Iron-overload cardiomyopathy is a prevalent cause of heart failure on a world-wide basis and is a major cause of mortality and morbidity in patients with secondary iron-overload and genetic hemochromatosis. We investigated the therapeutic effects of resveratrol in acquired and genetic models of iron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Subhash K., Wang, Wang, Zhabyeyev, Pavel, Basu, Ratnadeep, McLean, Brent, Fan, Dong, Parajuli, Nirmal, DesAulniers, Jessica, Patel, Vaibhav B., Hajjar, Roger J., Dyck, Jason R. B., Kassiri, Zamaneh, Oudit, Gavin Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671148/ https://www.ncbi.nlm.nih.gov/pubmed/26638758 http://dx.doi.org/10.1038/srep18132

Ejemplares similares

Females Are Protected From Iron‐Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress
por: Das, Subhash K., et al.
Publicado: (2017)

Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy
por: Das, Subhash K., et al.
Publicado: (2018)

Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues
por: Wang, Wang, et al.
Publicado: (2013)

PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular Dysfunction
por: McLean, Brent A., et al.
Publicado: (2019)

ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity
por: Patel, Vaibhav B., et al.
Publicado: (2016)

PI3Kα-regulated gelsolin activity is a critical determinant of cardiac cytoskeletal remodeling and heart disease
por: Patel, Vaibhav B., et al.
Publicado: (2018)

Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications
por: Zhabyeyev, Pavel, et al.
Publicado: (2023)

Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in Pathophysiology
por: Putko, Brendan N., et al.
Publicado: (2014)

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
por: Oudit, Gavin Y., et al.
Publicado: (2010)

Transcriptomic Signatures of End-Stage Human Dilated Cardiomyopathy Hearts with and without Left Ventricular Assist Device Support
por: Parikh, Mihir, et al.
Publicado: (2022)

ADAM (a Disintegrin and Metalloproteinase) 15 Deficiency Exacerbates Ang II (Angiotensin II)–Induced Aortic Remodeling Leading to Abdominal Aortic Aneurysm
por: Jana, Sayantan, et al.
Publicado: (2020)

Loss of PI3Kα Mediates Protection From Myocardial Ischemia–Reperfusion Injury Linked to Preserved Mitochondrial Function
por: Zhabyeyev, Pavel, et al.
Publicado: (2023)

Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs
por: Wang, Wang, et al.
Publicado: (2019)

Soluble Epoxide Hydrolase in Aged Female Mice and Human Explanted Hearts Following Ischemic Injury
por: Jamieson, K. Lockhart, et al.
Publicado: (2021)

Biology of Tissue Inhibitor of Metalloproteinase 3 (TIMP3), and Its Therapeutic Implications in Cardiovascular Pathology
por: Fan, Dong, et al.
Publicado: (2020)

Modulation of Cardiac Fibrosis in and Beyond Cells
por: Fan, Dong, et al.
Publicado: (2021)

Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy
por: Oudit, Gavin Y., et al.
Publicado: (2006)

Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility
por: Viveiros, Anissa, et al.
Publicado: (2022)

Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure
por: Byrne, Nikole J., et al.
Publicado: (2017)

Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts
por: Jana, Sayantan, et al.
Publicado: (2018)

PI3Kα in cardioprotection: Cytoskeleton, late Na(+) current, and mechanism of arrhythmias
por: Zhabyeyev, Pavel, et al.
Publicado: (2019)

Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
por: Fan, Dong, et al.
Publicado: (2012)

The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis
por: Chute, Michael, et al.
Publicado: (2019)

Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm
por: Jana, Sayantan, et al.
Publicado: (2019)

Prooxidant Mechanisms in Iron Overload Cardiomyopathy
por: Cheng, Ching-Feng, et al.
Publicado: (2013)

Loss of Angiotensin-Converting Enzyme-2 Leads to the Late Development of Angiotensin II-Dependent Glomerulosclerosis
por: Oudit, Gavin Y., et al.
Publicado: (2006)

Lipid overload - a culprit for hypertrophic cardiomyopathy?
por: Zhang, Lilei, et al.
Publicado: (2023)

Duality of Nrf2 in iron-overload cardiomyopathy
por: Federti, Enrica, et al.
Publicado: (2023)

Protective effect of resveratrol against pressure overload-induced heart failure
por: Gupta, Prakash K, et al.
Publicado: (2014)

The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review
por: Dyck, Garrison J. B., et al.
Publicado: (2019)

Resveratrol ameliorates iron overload induced liver fibrosis in mice by regulating iron homeostasis
por: Wang, Hua, et al.
Publicado: (2022)

A Role of Glucose Overload in Diabetic Cardiomyopathy in Nonhuman Primates
por: Wang, Xiu, et al.
Publicado: (2021)

Sudden Onset Iron Overload Cardiomyopathy After Liver Transplantation
por: Habib, Alma, et al.
Publicado: (2023)

ACE2 Deficiency Enhances Angiotensin II-Mediated Aortic Profilin-1 Expression, Inflammation and Peroxynitrite Production
por: Jin, Hai-Yan, et al.
Publicado: (2012)

Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms
por: Song, Yan-Jun, et al.
Publicado: (2020)

Experimental Studies of the Molecular Pathways Regulated by Exercise and Resveratrol in Heart, Skeletal Muscle and the Vasculature
por: Dolinsky, Vernon W., et al.
Publicado: (2014)

Guidelines for measuring cardiac physiology in mice
por: Lindsey, Merry L., et al.
Publicado: (2018)

Left Ventricular Remodeling in Non-syndromic Mitral Valve Prolapse: Volume Overload or Concomitant Cardiomyopathy?
por: Pype, Lobke L., et al.
Publicado: (2022)

The Human Explanted Heart Program: A translational bridge for cardiovascular medicine
por: Zhang, Hao, et al.
Publicado: (2021)

Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs
por: Salla, Mohamed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_galnja5k04q8bid1qv6hrl1psu